Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PARP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Testing effectiveness (Phase 2)Study completedNCT04209686
What this trial is testing

Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma

Who this might be right for
Advanced Gastric Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Large-scale testing (Phase 3)Study completedNCT02264990
What this trial is testing

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
AbbVie 595
Early research (Phase 1)Study completedNCT01139970
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+13 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT02289690
What this trial is testing

Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 221
Testing effectiveness (Phase 2)Looking for participantsNCT04086485
What this trial is testing

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Who this might be right for
Gastroenteropancreatico TumorsNeuroendocrine TumorsNeuroendocrine Neoplasms
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Testing effectiveness (Phase 2)Ended earlyNCT04377087
What this trial is testing

Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sarah E Taylor 3
Testing effectiveness (Phase 2)Study completedNCT02860819
What this trial is testing

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

Who this might be right for
Testicular Cancer
National Cancer Institute, Slovakia 15
Large-scale testing (Phase 3)Study completedNCT01847274
What this trial is testing

A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsPlatinum Sensitive Ovarian Cancer
Tesaro, Inc. 596
Early research (Phase 1)Study completedNCT01749397
What this trial is testing

Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Stage IV Fallopian Tube Cancer AJCC v6 and v7Stage IV Ovarian Cancer AJCC v6 and v7Stage IV Primary Peritoneal Cancer AJCC v7
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT01009190
What this trial is testing

Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens

Who this might be right for
Advanced Solid Tumors
pharmaand GmbH 85
Testing effectiveness (Phase 2)UnknownNCT05392686
What this trial is testing

PD1 and PARP for Maintenance Therapy in NSLLC

Who this might be right for
Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 52
Early research (Phase 1)Study completedNCT02324998
What this trial is testing

Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT04335604
What this trial is testing

NOV140201 (JPI-547) in Subject With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Onconic Therapeutics Inc. 62
Testing effectiveness (Phase 2)Study completedNCT04209595
What this trial is testing

PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers

Who this might be right for
Small Cell Lung CancerExtra-Pulmonary Small Cell Carcinomas
National Cancer Institute (NCI) 10
Early research (Phase 1)Study completedNCT02660034
What this trial is testing

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumors
BeiGene 229
Large-scale testing (Phase 3)Not Yet RecruitingNCT07743164
What this trial is testing

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Merck Sharp & Dohme LLC 646
Early research (Phase 1)Study completedNCT03329001
What this trial is testing

Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule

Who this might be right for
Neoplasms
Tesaro, Inc. 236
Not applicableEnded earlyNCT04367467
What this trial is testing

Effect of PARP Inhibitors on Glomerular Filtration Rate

Who this might be right for
Solid TumorOvarian CancerBreast Cancer
University of Pennsylvania 2
Next Page